bionanogenomics.com (BNGO) - Company Total Sales Volume

Bionano Genomics Inc. - graphic logo of issuer BNGO

Bionano Genomics, Inc. (BNGO) is developing a closed-loop optical DNA analysis ecosystem via Saphyr. The company's current sales momentum confirms this trajectory, with 0.03 serving as the current value of the metric. Business stability relies on US-based production of unique diagnostic equipment; however, a heavy dependence on a single product and high overhead costs create risks for the balance sheet amid slow technology adoption.

BNGO Bionano Genomics: Company Revenue in the range 07/04/2022 - 11/17/2026

Analytical breakdowns for Bionano Genomics, Inc.

Summary company analysis:Bionano Genomics, Inc.
Original product of Bionano Genomics, Inc.

The stability of Bionano Genomics, Inc. (BNGO) cash flows correlates directly with the adoption rates of optical genome mapping systems within research centers. The company's sales volume dynamics capture the daily inflow of funds from equipment sales, allowing investors to identify the formation phase of a fundamental revenue floor and avoid a value trap when analyzing capital volatility.

Key competitors

Tempus AI, Inc. (TEM) - Company Gross Revenue|Company Sales QGEN (Qiagen NV)|Revenue and Sales Volume Ionis Pharmaceuticals, Inc. (IONS)|Revenue and Sales Volume RGEN (Repligen Inc.)|Avidity Corp (RNA) - Company Total Revenue|CRSP - Company Revenue|Company Gross Revenue genedx.com WGS|Ultragenyx Pharmaceutical (RARE) - Company Revenue|Company Total Revenue Beam Therapeutics Corp (BEAM)|SRPT (Sarepta Therapeutics) - Revenue and Sales Volume|Company Total Revenue Twist Bioscience Corp TWST|Revenue and Sales Volume TXG|Revenue and Sales Volume intelliatx.com (NTLA)|Stoke Therapeutics - Company Sales|BioLife Solutions Inc (BLFS) - Company Total Revenue|wavelifesciences.com - Revenue and Sales Volume|Maze Therapeutics Corp (MAZE) - Company Sales|SION: Revenue and Sales Volume|Company Sales Volume PRME|Company Revenue Taysha Gene Therapies|Company Sales Volume QURE (uniQure)|Company Revenue MeiraGTx (MGTX)|REGENXBIO Corp - Company Sales Volume|Company Revenue Solid Biosciences SLDB|OCGN - Company Sales|pacb.com - Revenue and Sales Volume|Benitec (BNTC) - Company Sales|DSGN: Revenue and Sales Volume|RCKT - Company Gross Revenue|FDMT: Company Gross Revenue|Company Sales Volume LXEO (lexeotx.com)|Company Revenue Korro Bio Inc. (KRRO)|Company Total Sales EDIT|Revenue and Sales Volume SLN (Silence Therapeutics PLC)|Company Sales Revenue PRQR|CDXS - Company Revenue|SGMO (Sangamo Therapeutics) - Company Sales Volume|NAUT: Revenue and Sales Volume|Company Sales Volume MGX|DTIL (precisionbiosciences.com) - Revenue and Sales Volume|Company Sales Volume GBIO (Generation Bio Co.)|Company Revenue Boundless Bio (BOLD)|Exicure - Company Sales Volume|Revenue and Sales Volume IMNN (imunon.com)|Company Gross Revenue Phio Pharmaceuticals (PHIO)|MBIO: Company Sales|Company Sales Revenue RNAZ (transcodetherapeutics.com)|APDN: Revenue and Sales Volume|Company Sales Volume BLUE|Company Sales IPA|OMGA: Company Sales Revenue|Revenue and Sales Volume OMIC|Company Gross Revenue Regulus Therapeutics|Company Revenue Syros SYRS|Company Sales Revenue TBIO|TCON: Company Sales|Unity Biotechnology, Inc. (UBX) - Company Sales